Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects
about
Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectivesTafenoquine at therapeutic concentrations does not prolong Fridericia-corrected QT interval in healthy subjects.A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area.[Plasmodium vivax malaria recurrence according to the use of primaquine: analysis of longitudinal descriptive studies].
P2860
Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects
@ast
Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects
@en
type
label
Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects
@ast
Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects
@en
prefLabel
Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects
@ast
Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects
@en
P2093
P2860
P356
P1476
Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects
@en
P2093
Ann K Miller
Bruce G Charles
Ivor E Harris
Mark G Reid
Michael D Edstein
Peter E Nasveld
P2860
P304
P356
10.1128/AAC.01183-06
P407
P577
2007-05-21T00:00:00Z